(Q40829792)

English

Influences of sex and smoking habits on anticoagulant activity in low-molecular-weight heparin treatment of unstable coronary artery disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Influences of sex and smoking habits on anticoagulant activity in low-molecular-weight heparin treatment of unstable coronary artery disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

anticoagulation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Toss H

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Wallentin L

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Siegbahn A

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

language of work or name

0 references

publication date

1 January 1999

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

American Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

137

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

72-78

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970461-8

7 January 2021

Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low-molecular-weight heparin, and dermatan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970461-8

7 January 2021

The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mg.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970461-8

7 January 2021

The disappearance of a low molecular weight heparin fraction (CY 216) differs from standard heparin in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970461-8

7 January 2021

Low molecular weight heparin half life is prolonged in haemodialysed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970461-8

7 January 2021

Comparison of low molecular weight heparin vs. unfractionated heparin in gynecological surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970461-8

7 January 2021

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970461-8

7 January 2021

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970461-8

7 January 2021

Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970461-8

7 January 2021

Reduction of reinfarction and angina with use of low-molecular-weight heparin therapy after streptokinase (and heparin) in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970461-8

7 January 2021

Randomized trial of low molecular weight heparin (dalteparin) in prevention of left ventricular thrombus formation and arterial embolism after acute anterior myocardial infarction: the Fragmin in Acute Myocardial Infarction (FRAMI) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970461-8

7 January 2021

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970461-8

7 January 2021

Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970461-8

7 January 2021

Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970461-8

7 January 2021

Predictors of the Effect of Heparin during Cardiac Catheterization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970461-8

7 January 2021

Heparin kinetics: variables related to disposition and dosage

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970461-8

7 January 2021

Assay of unfractionated and LMW heparin with chromogenic substrates: twin methods with factor Xa and thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970461-8

7 January 2021

Thrombin generation as an acute effect of cigarette smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970461-8

7 January 2021

Persistent activation of coagulation mechanism in unstable angina and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970461-8

7 January 2021

Long-term low-molecular-weight heparin (Fragmin) and/or early revascularization during instability in coronary artery disease (the FRISC II Study).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970461-8

7 January 2021

Identifiers

10.1016/S0002-8703(99)70461-8

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40829792&oldid=1908303888"